Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (XPAE:PHARMACARE) COGS-to-Revenue : 0.76 (As of Dec. 2021)

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals COGS-to-Revenue Chart

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21
COGS-to-Revenue		Get a 7-Day Free Trial					0.67	0.58	0.81	0.63	0.63

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Sep21	Dec21
COGS-to-Revenue	Get a 7-Day Free Trial															0.71	0.59	0.62	-	0.76

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals COGS-to-Revenue Calculation

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's COGS to Revenue for the quarter that ended in Dec. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals  (XPAE:PHARMACARE) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Gross Margin % for the three months ended in Dec. 2021 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Business Description